Colloidal Silicon Dioxide Pharmaceutical Use

Colloidal Silicon Dioxide Pharmaceutical Use

Colloidal Silicon Dioxide for Pharmaceutical Use

Colloidal silicon dioxide (SiO₂), produced by flame hydrolysis of silicon tetrachloride, consists of sub‑micron amorphous particles that aggregate into loosely bound agglomerates. Its primary technical role in drug‑product manufacturing is to modify powder flow characteristics and to adsorb moisture or active ingredients.

Key Technical Properties

Typical values depend on the specific grade and production conditions; the following table lists common ranges for pharmaceutical‑grade colloidal silicon dioxide.

Property Typical Range Test Method (Reference)
Primary particle size (nm) 5 – 50 TEM / BET
Specific surface area (m²/g) 100 – 400 BET nitrogen adsorption
Loss on drying (% w/w) ≤ 1.0 USP <731>
pH (5% w/v dispersion) 3.5 – 5.0 USP <791>
Bulk density (g/L) 30 – 80 ASTM B329

Pharmaceutical Applications and Functional Rationale

In solid‑dosage manufacturing, colloidal silicon dioxide is added at low concentrations (typically 0.1 %–2.0 % w/w) to improve flow properties of blends that contain cohesive active pharmaceutical ingredients (APIs) or excipients such as lactose, microcrystalline cellulose, or starch.

  • Glidant: reduces inter‑particle friction, leading to higher hopper flow rates and more uniform die filling.
  • Anti‑caking agent: prevents agglomeration during storage, especially under humid conditions.
  • Adsorbent: can trap moisture or volatile oils, improving chemical stability of hygroscopic APIs.
  • Disintegration aid (in some formulations): creates micro‑channels that facilitate water penetration upon tablet immersion.

Manufacturing and Process Considerations

Because the particles are extremely light and prone to aerosolization, handling requires closed‑system transfer or local exhaust ventilation to maintain occupational exposure limits (OEL) typically set at 0.1 mg/m³ respirable silica.

Incorporation is usually performed via dry blending in a V‑cone, double‑cone, or tumble blender for 5–15 minutes; over‑blending can lead to excessive de‑agglomeration and potential changes in surface chemistry.

For aseptic products, colloidal silicon dioxide can be sterilized by dry heat (e.g., 160 °C for 2 h) or gamma irradiation without significant loss of surface area, provided the grade is specified as low‑endotoxin.

colloidal silicon dioxide pharmaceutical use

Quality Standards and Regulatory Compliance

Pharmaceutical‑grade colloidal silicon dioxide must meet the monographs of USP , EP, and JP. Key specifications include limits on heavy metals, loss on ignition, and microbial burden.

Parameter Limit (Typical) Reference
Heavy metals (as Pb) ≤ 10 ppm USP <231>
Loss on ignition (% w/w) ≤ 2.0 USP <731>
Microbial aerobic count (CFU/g) ≤ 10³ USP <61>
Endotoxin (EU/g) ≤ 0.5 (low‑endotoxin grade) USP <85>

Handling, Storage, and Safety

Store in a dry, temperature‑controlled environment (15 °C–25 °C) with relative humidity below 50 % to prevent moisture uptake that could alter flow properties.

Keep containers tightly sealed; use antistatic‑compatible liners if static discharge is a concern in high‑speed blending operations.

Refer to the Safety Data Sheet (SDS) for inhalation and skin‑contact precautions; engineering controls such as local exhaust ventilation are recommended during transfer.

Frequently Asked Questions

Can the particle size distribution be customized?
Yes. Grades are available with median primary particle sizes ranging from 10 nm to 30 nm, selected based on desired surface area and flow‑enhancement efficiency.
What information is required for a quotation?
Required details include target dosage form, intended concentration (% w/w), required regulatory grade (USP/EP/JP), packaging size, and any special handling constraints (e.g., low‑endotoxin, sterile‑grade).
Which packaging options are available for bulk pharmaceutical grades?
Standard options are multi‑layer polyethylene bags (25 kg) placed inside fiber drums, or rigid intermediate bulk containers (IBCs) with antistatic liners for larger volumes.
How is quality verified for each lot?
Each lot undergoes laser diffraction for particle size, BET for surface area, loss on drying, pH, heavy‑metal testing, and microbial limits; a certificate of analysis (CoA) is provided.

Request Technical Documentation or Sample

To obtain a certificate of analysis, safety data sheet, or to arrange a sample evaluation, please contact our technical support team.

Contact Technical Support